The Traderszone Network

Published in TZ Latest News 22 December, 2021 by The TZ Newswire Staff

ABVC BioPharma’s Vitreous Substitute Vitargus Presented at 14th APVRS Congress

Fremont, CA, Dec. 22, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that Vitargus®, the world’s first bio-degradable vitreous substitute, was presented by Dr.

read more